100 cases in normal ovarian control group, 100 cases in benign ovarian disease group and 100 cases in malignant ovarian epithelial carcinoma group will be studied. Change regularity of ovarian cancer specific immune inflammation-related protein complexes in blood will be studied. The relationship between disease-specific protein complexes and pathological state of patients will be analyzed.
Age
20–70
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Female
Normal ovary control
Ovarian benign disease
Ovarian malignant epithelial carcinoma
You may not be if
Male
Age above 70
Suffering from other malignant tumors
Non-compliant patient
Clareo Health | Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer
